IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways

Nucleic Acids Res. 2001 Nov 1;29(21):4361-72. doi: 10.1093/nar/29.21.4361.

Abstract

Osteoarthritic chondrocytes secrete matrix metalloproteinase-13 (MMP-13) in response to interleukin-1 (IL-1), causing digestion of type II collagen in cartilage. Using chondrocytic cells, we previously determined that IL-1 induced a strong MMP-13 transcriptional response that requires p38 MAPK, JNK and the transcription factor NF-kappaB. Now, we have studied the tissue-specific transcriptional regulation of MMP-13. Constitutive expression of the transcription factor Runx-2 correlated with the ability of a cell type to express MMP-13 and was required for IL-1 induction; moreover, Runx-2 enhanced IL-1 induction of MMP-13 transcription by synergizing with the p38 MAPK signaling pathway. Transiently transfected MMP-13 promoters were not IL-1 inducible. However, -405 bp of stably integrated promoter was sufficient for 5- to 6-fold IL-1 induction of reporter activity and this integrated reporter required the same p38 MAPK pathway as the endogenous gene. Finally, mutation of the proximal Runx binding site and the proximal AP-1 site blunted the transcriptional response to IL-1, and double mutation synergistically decreased reporter activity. In summary, our data suggest that the transcriptional MMP-13 response to IL-1 is controlled by the p38 pathway interacting at the MMP-13 promoter through the tissue-specific transcription factor Runx-2 and the ubiquitous AP-1 transcription factor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Base Sequence
  • Chondrocytes / drug effects
  • Chondrocytes / metabolism*
  • Collagenases / biosynthesis
  • Collagenases / genetics*
  • Core Binding Factor Alpha 1 Subunit
  • Core Binding Factor alpha Subunits
  • DNA-Binding Proteins / chemistry
  • Drosophila Proteins
  • Fibroblasts
  • Genes, Reporter / genetics
  • Humans
  • Imidazoles / pharmacology
  • Interleukin-1 / pharmacology*
  • JNK Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 3
  • MAP Kinase Kinase Kinase 1*
  • MAP Kinase Signaling System / drug effects*
  • Matrix Metalloproteinase 13
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Mitogen-Activated Protein Kinases / metabolism*
  • Molecular Sequence Data
  • Mutation / genetics
  • NF-kappa B / metabolism
  • Neoplasm Proteins*
  • Nuclear Proteins
  • Promoter Regions, Genetic / genetics
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism
  • Protein Structure, Tertiary
  • Protein-Tyrosine Kinases / metabolism
  • Pyridines / pharmacology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Response Elements / genetics
  • Transcription Factor AP-1 / metabolism
  • Transcription Factors / genetics
  • Transcription Factors / metabolism*
  • Tumor Cells, Cultured
  • Up-Regulation / drug effects
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Core Binding Factor Alpha 1 Subunit
  • Core Binding Factor alpha Subunits
  • DNA-Binding Proteins
  • Drosophila Proteins
  • Imidazoles
  • Interleukin-1
  • NF-kappa B
  • Neoplasm Proteins
  • Nuclear Proteins
  • Pyridines
  • RNA, Messenger
  • Transcription Factor AP-1
  • Transcription Factors
  • run protein, Drosophila
  • Protein-Tyrosine Kinases
  • Protein Serine-Threonine Kinases
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase Kinase 1
  • MAP3K1 protein, human
  • MAP Kinase Kinase 3
  • MAP2K3 protein, human
  • Mitogen-Activated Protein Kinase Kinases
  • Collagenases
  • MMP13 protein, human
  • Matrix Metalloproteinase 13
  • SB 203580